Tag Archives: Theoharis C Theoharides

Research review: Genetics of COVID-19 & ME/CFS

Posted on 10/11/2022 by wames

Genetics of COVID-19 and ME/CFS: a systematic review   Greek researchers found 71 studies for COVID-19 and 26 studies for ME/CFS that looked at genes. They concluded: “In spite of the fact that COVID-19 and ME/CFS present with some similar … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Research review: Genetics of COVID-19 & ME/CFS

Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?

Posted on 05/02/2019 by wames

Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?, by Theoharis C. Theoharides, Irene Tsilioni & Huali Ren in Expert Review of Clinical Immunology [Published online: 22 Apr 2019, https://doi.org/10.1080/1744666X.2019.1596800]   … Continue reading →

Posted in News | Tagged , , , , | Comments Off on Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?

ME/CFS – Metabolic disease or disturbed homeostasis?

Posted on 08/16/2018 by wames

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis? by Erifili Hatziagelaki, Maria Adamaki, Irene Tsilioni, George Dimitriadis and Theoharis C Theoharides in Journal of Pharmacology and Experimental Therapeutics August 3, 2018, jpet.118.250845 Research article abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a complex disease characterized by debilitating fatigue, lasting … Continue reading →

Posted in News | Tagged , , , , , , , , | Comments Off on ME/CFS – Metabolic disease or disturbed homeostasis?